Narda Theobald
Impact in
- Genetics top 10%
- Virus-based gene therapy research
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immunodeficiency and Autoimmune Disorders
Papers in
-
- CRISPR and Genetic Engineering 5
- RNA Interference and Gene Delivery 3
- Genetics 9
- Virus-based gene therapy research 7
- Co-authors
- Harry L. Malech (18 shared papers)Uimook Choi (8 shared papers)Elizabeth M. Kang (8 shared papers)Gilda F. Linton (4 shared papers)Debra A. Long Priel (1 shared paper)Suk See De Ravin (9 shared papers)Paul Gardner (1 shared paper)Colin L. Sweeney (4 shared papers)
- Journals
- Blood (7 papers)Journal of Clinical Immunology (3 papers)Human Gene Therapy (1 paper)Science Translational Medicine (1 paper)Molecular Therapy (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Narda Theobald
19 papers receiving 470 citations
Peers
Comparison fields: 5 of 55
- Genetics 208
- Immunology 150
- Virology 33
- Hematology 58
- Molecular Biology 297
Countries citing papers authored by Narda Theobald
This map shows the geographic impact of Narda Theobald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narda Theobald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narda Theobald more than expected).
Fields of papers citing papers by Narda Theobald
This network shows the impact of papers produced by Narda Theobald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narda Theobald. The network helps show where Narda Theobald may publish in the future.
Co-authors
The 25 scholars most cited alongside Narda Theobald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 117 | |
| 2 | 2014 | 80 | |
| 3 | 2013 | 70 | |
| 4 | 2001 | 45 | |
| 5 | 2021 | 34 | |
| 6 | 2017 | 33 | |
| 7 | 1994 | 27 | |
| 8 | 2015 | 26 | |
| 9 | 2020 | 11 | |
| 10 | 2020 | 9 | |
| 11 | 2024 | 7 | |
| 12 | 2021 | 4 | |
| 13 | 2010 | 3 | |
| 14 | 2015 | 3 | |
| 15 | 2015 | 2 | |
| 16 | 2015 | 1 | |
| 17 | 2007 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2008 | 1 |
About Narda Theobald
Narda Theobald is a scholar working on Molecular Biology, Genetics, Immunology, Oncology and Infectious Diseases, having authored 19 papers that have together received 475 indexed citations. Recurring topics across this work include Virus-based gene therapy research (7 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers), CRISPR and Genetic Engineering (5 papers), Cytomegalovirus and herpesvirus research (3 papers), Antifungal resistance and susceptibility (3 papers), RNA Interference and Gene Delivery (3 papers), CAR-T cell therapy research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Genetics (208 citations), Immunology (150 citations), Virology (33 citations), Hematology (58 citations) and Molecular Biology (297 citations). Narda Theobald has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Harry L. Malech, Uimook Choi, Elizabeth M. Kang, Gilda F. Linton, Debra A. Long Priel, Suk See De Ravin, Paul Gardner, Colin L. Sweeney, Sherry Koontz and Xiaolin Wu. Their work appears in journals such as Blood, Journal of Clinical Immunology, Human Gene Therapy, Science Translational Medicine and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.